Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the resistance of HCC cells to traditional treatments and tumor recurrence after curative therapies. Cancer stem cells (CSCs) have been identified as a small subset of cancer cells which have high capacity for self-r...
Main Authors: | Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-12-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835918816287 |
Similar Items
-
Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach
by: Wei M, et al.
Published: (2023-02-01) -
EPHA2, a promising therapeutic target for hepatocellular carcinoma
by: Hao Wang, et al.
Published: (2021-05-01) -
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
by: Junnv Xu, et al.
Published: (2021-12-01) -
Sirtuins: Promising Therapeutic Targets to Treat Ischemic Stroke
by: Yue Liu, et al.
Published: (2023-08-01) -
Antimicrobial peptides: an overview of a promising class of therapeutics
by: Giuliani Andrea, et al.
Published: (2007-03-01)